Key facts
- This page summarizes Ann E. Berman's Form 3 filing for Immuneering Corp (IMRX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2021, 20:49.
Ann E. Berman - 29 Jul 2021 Form 3 Insider Report for Immuneering Corp (IMRX)
- Reporting relationship
- Director
- Issuer ticker
- IMRX
- Reported as of
- 29 Jul 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 29 Jul 2021, 20:49:41 UTC
- Prior SEC filing
- 02 Jun 2021
- Next SEC filing
- 04 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael D. Bookman, Attorney-in-Fact for Ann E. Berman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ann E. Berman filed Form 3 for Immuneering Corp (IMRX) on 29 Jul 2021.
Change
- Previous filing in this sequence was filed on 02 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit 24 - Power of Attorney